| Primary |
| Muscle Spasticity |
96.5% |
| Cerebral Palsy |
0.6% |
| Multiple Sclerosis |
0.5% |
| Spinal Cord Injury |
0.4% |
| Pain |
0.3% |
| Hypertension |
0.2% |
| Spasticity |
0.2% |
| Dystonia |
0.2% |
| Muscle Spasms |
0.1% |
| Migraine |
0.1% |
| Diabetes Mellitus |
0.1% |
| Neuralgia |
0.1% |
| Muscle Relaxant Therapy |
0.1% |
| Spinal Cord Disorder |
0.1% |
| Cerebrovascular Accident |
0.1% |
| Brain Injury |
0.1% |
| Head Injury |
0.1% |
| Epilepsy |
0.1% |
| Product Used For Unknown Indication |
0.1% |
| Convulsion |
0.1% |
|
| Hypertonia |
18.1% |
| Drug Ineffective |
10.5% |
| Withdrawal Syndrome |
9.1% |
| Pain |
7.4% |
| Death |
7.1% |
| Muscle Spasticity |
6.4% |
| Somnolence |
4.6% |
| Overdose |
4.3% |
| Therapeutic Response Decreased |
4.2% |
| Infection |
3.9% |
| Vomiting |
3.4% |
| Pruritus |
3.3% |
| Underdose |
2.9% |
| Pyrexia |
2.8% |
| Drug Withdrawal Syndrome |
2.6% |
| Hypotonia |
2.2% |
| Therapy Cessation |
2.2% |
| Urinary Tract Infection |
1.8% |
| Medical Device Complication |
1.6% |
| Tremor |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
20.8% |
| Drug Use For Unknown Indication |
14.6% |
| Muscle Spasticity |
13.5% |
| Pain |
6.8% |
| Multiple Sclerosis |
5.9% |
| Depression |
5.1% |
| Hypertension |
4.6% |
| Relapsing-remitting Multiple Sclerosis |
3.8% |
| Epilepsy |
3.4% |
| Muscle Spasms |
3.1% |
| Drug Dependence |
2.8% |
| Migraine |
2.5% |
| Insomnia |
2.1% |
| Cerebrovascular Accident |
1.8% |
| Anxiety |
1.7% |
| Sedation |
1.7% |
| Anaemia |
1.5% |
| Paraplegia |
1.4% |
| Post Laminectomy Syndrome |
1.4% |
| Trigeminal Neuralgia |
1.4% |
|
| Thirst |
9.9% |
| Somnolence |
9.1% |
| Withdrawal Syndrome |
8.3% |
| Pain |
7.4% |
| Thrombocytopenia |
7.4% |
| Vomiting |
7.4% |
| Pancreatitis Acute |
5.0% |
| Hypomania |
4.1% |
| Irritability |
4.1% |
| Muscle Spasticity |
4.1% |
| Pyrexia |
4.1% |
| Alanine Aminotransferase Increased |
3.3% |
| Coma |
3.3% |
| Epilepsy |
3.3% |
| Infrequent Bowel Movements |
3.3% |
| Seroma |
3.3% |
| Sopor |
3.3% |
| Toxic Encephalopathy |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Angiopathy |
2.5% |
|
| Concomitant |
| Multiple Sclerosis |
20.5% |
| Product Used For Unknown Indication |
12.8% |
| Pain |
7.8% |
| Muscle Spasticity |
7.4% |
| Drug Use For Unknown Indication |
6.0% |
| Prophylaxis |
5.7% |
| Relapsing-remitting Multiple Sclerosis |
5.0% |
| Convulsion |
4.4% |
| Hypertension |
4.1% |
| Depression |
3.5% |
| Epilepsy |
3.3% |
| Amyotrophic Lateral Sclerosis |
3.3% |
| Constipation |
2.6% |
| Insomnia |
2.5% |
| Hepatitis B |
2.3% |
| Muscle Spasms |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Anxiety |
1.7% |
| Analgesic Therapy |
1.6% |
| Neuralgia |
1.4% |
|
| Urinary Tract Infection |
13.7% |
| Progressive Multifocal Leukoencephalopathy |
9.7% |
| White Blood Cell Count Decreased |
8.3% |
| Pneumonia |
7.9% |
| Vomiting |
6.1% |
| Urinary Retention |
5.8% |
| Pyrexia |
5.4% |
| Multiple Sclerosis Relapse |
5.0% |
| Thrombocytopenia |
5.0% |
| Blood Alkaline Phosphatase Increased |
3.6% |
| Visual Impairment |
3.6% |
| Somnolence |
3.2% |
| Wheelchair User |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Muscular Weakness |
2.9% |
| Pulmonary Embolism |
2.9% |
| Wrong Technique In Drug Usage Process |
2.9% |
| Lymphocytosis |
2.5% |
| Muscle Spasticity |
2.5% |
| Tachycardia |
2.5% |
|
| Interacting |
| Huntington's Chorea |
14.3% |
| Pain |
14.3% |
| Product Used For Unknown Indication |
14.3% |
| Acne |
7.1% |
| Epilepsy |
7.1% |
| Gastrooesophageal Reflux Disease |
7.1% |
| Multiple Sclerosis |
7.1% |
| Alcohol Detoxification |
3.6% |
| Alcoholism |
3.6% |
| Cervicobrachial Syndrome |
3.6% |
| Depression |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Muscle Spasms |
3.6% |
| Musculoskeletal Pain |
3.6% |
| Sleep Disorder |
3.6% |
|
| Somnolence |
21.4% |
| Drug Interaction |
14.3% |
| Hypoxia |
14.3% |
| Bradycardia |
7.1% |
| Epilepsy |
7.1% |
| Grand Mal Convulsion |
7.1% |
| Hallucination, Visual |
7.1% |
| Respiratory Depression |
7.1% |
| Sopor |
7.1% |
| Tremor |
7.1% |
|
